Released today, the Scottish Stroke Improvement Programme 2016 Annual National Report includes data from the Scottish Stroke Care Audit. It describes the quality of stroke care in each acute hospital in Scotland, grouped by Health Board, during 2015, and measures each hospital against Scottish Stroke Care Standards (2013).
A panel of independent experts has decided that alteplase, a clot-busting drug often used to treat strokes is safe and effective under current guidelines.
A clinical trial to examine if it is effective to use everyday drugs to treat common stroke complications such as fever and infection.
Browse through a list of organisations that can provide information and support for patients.
Browse through a list of organisations that can provide information and support for carers.
The Stroke Association's response to the latest National Clinical Guideline for Stroke (2016) produced by the Intercollegiate Stroke Working Party of the Royal College of Physicians of London.
A Post-Stroke Review identifies the unmet needs of stroke survivors and their carers, which our coordinators then address. They also carry out checks to highlight unidentified high blood pressure or Atrial Fibrillation.
Two articles published from the Nottingham Fatigue After Stroke (NOTFAST) study shed light on having fatigue six months after having a stroke.
At present it is not clear how best to organise NHS services so that patients can benefit from threombectomy for stroke. The Institute of Heath Services, Newcastle University, has produced an online survey to understand the preferences of stroke survivors, their carers and the public on the future of stroke thrombectomy service organisation in the UK.
Alteplase-Tenecteplase Trial Evaluation for Stroke Thrombolysis (ATTEST 2) - TSA BHF 2015/01